Heart-Valve Win May Prod Johnson & Johnson, Abbott Laboratories to Shop for Technology

November 10, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Bloomberg -- Abbott Laboratories and Johnson & Johnson, pursuing a potential $2 billion market for heart valves that don’t require rib-cracking surgery, are shopping for companies with the new technology.

Twitter
LinkedIn
Facebook
Email
Print

Mergers & acquisitions

Johnson & Johnson Family of Companies Abbott Laboratories